August Garin

1.8k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

August Garin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, August Garin has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in August Garin's work include Testicular diseases and treatments (5 papers), Estrogen and related hormone effects (3 papers) and Advanced Breast Cancer Therapies (2 papers). August Garin is often cited by papers focused on Testicular diseases and treatments (5 papers), Estrogen and related hormone effects (3 papers) and Advanced Breast Cancer Therapies (2 papers). August Garin collaborates with scholars based in Russia, United States and France. August Garin's co-authors include Jaffer A. Ajani, István Láng, S. Falcon, Vladimir Moiseyenko, Mikhail Lichinitser, G. Bodoky, В. А. Горбунова, Ihor Vynnychenko, W. Rodriguez and В. П. Шелепов and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Chemistry.

In The Last Decade

August Garin

13 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial

2010 425 citations Jaffer A. Ajani, W. Rodriguez et al. Journal of Clinical Oncology profile →

Peers

August Garin

PRM

ONCOL

SURGE

Gordon A. MacKinlay United Kingdom

Jung‐Sun Kim South Korea

Zahir Soonawalla United Kingdom

Geert Roeyen Belgium

I. D. Werner South Africa

Andrea Gardini Italy

Matsuo Nagata Japan

Shin‐ichi Kosugi Japan

M. Henar Alonso United States

Joung‐Ho Han South Korea

Gordon A. MacKinlay United Kingdom

August Garin

250 ×0.4

PRM

493 ×1.0

ONCOL

788 ×2.0

SURGE

286 ×0.9

202 ×0.7

Citations per year, relative to August Garin August Garin (= 1×) peers Gordon A. MacKinlay

Countries citing papers authored by August Garin

Since Specialization

Citations

This map shows the geographic impact of August Garin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by August Garin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites August Garin more than expected).

Fields of papers citing papers by August Garin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by August Garin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by August Garin. The network helps show where August Garin may publish in the future.

Co-authorship network of co-authors of August Garin

This figure shows the co-authorship network connecting the top 25 collaborators of August Garin. A scholar is included among the top collaborators of August Garin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with August Garin. August Garin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Tryakin, A., et al.. (2015). Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors. Journal of Cancer Research and Clinical Oncology. 141(7). 1259–1264. 1 indexed citations

Fedyanin, М. Yu., et al.. (2013). Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors. Journal of Cancer Research and Clinical Oncology. 140(2). 311–318. 10 indexed citations

Tryakin, A., et al.. (2013). Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis. Urologic Oncology Seminars and Original Investigations. 32(1). 32.e27–32.e33. 3 indexed citations

Poplin, Elizabeth, Harpreet Wasan, Lindsey Rolfe, et al.. (2013). Randomized multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) and a prospective evaluation of the of the association between tumor hENT1 expression and clinical outcome with gemcitabine treatment.. Journal of Clinical Oncology. 31(15_suppl). 4007–4007. 10 indexed citations

Wit, Ronald de, Iwona Skoneczna, Gedske Daugaard, et al.. (2012). Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983. Journal of Clinical Oncology. 30(8). 792–799. 47 indexed citations

Wolff, Antonio C., Ann Lazar, Igor Bondarenko, et al.. (2012). Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology. 31(2). 195–202. 222 indexed citations

Buzdar, Aman U., Charles Vogel, Lee Schwartzberg, et al.. (2011). Randomized double‐blind phase 2 trial of 3 doses of TAS‐108 in patients with advanced or metastatic postmenopausal breast cancer. Cancer. 118(13). 3244–3253. 4 indexed citations

Fedyanin, М. Yu., et al.. (2011). Late relapses (>2 years) in patients with stage I testicular germ cell tumors: Predictive factors and survival. Urologic Oncology Seminars and Original Investigations. 31(4). 499–504. 5 indexed citations

Ajani, Jaffer A., W. Rodriguez, G. Bodoky, et al.. (2010). Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial. Journal of Clinical Oncology. 28(9). 1547–1553. 425 indexed citations breakdown →

10.

Garin, August, et al.. (2007). A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer. Breast Cancer Research and Treatment. 110(2). 309–315. 24 indexed citations

11.

Belle, Simon Van, M. Lichinitser, Rudolph M. Navari, et al.. (2002). Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869. Cancer. 94(11). 3032–3041. 115 indexed citations

12.

Botezatu, I. V., Г. И. Потапова, В. П. Шелепов, et al.. (2000). Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism. Clinical Chemistry. 46(8). 1078–1084. 305 indexed citations

13.

Gershanovich, M., et al.. (1997). A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Breast Cancer Research and Treatment. 45(3). 251–262. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact